Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06153381
Other study ID # SIP_LaFe
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date June 1, 2024

Study information

Verified date December 2023
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

reverse shoulder replacement surgery is performed to improve the functionality and reduce pain of the affected shoulder. Now, it is necessary to carry out an appropriate rehabilitation process to optimize surgical results. The lack of health resources makes it essential for the patient to work autonomously once hospital rehabilitation is completed. But lack of adherence is one of the main barriers to recovery


Description:

The objective is to evaluate the effectiveness of a Chatbot that interacts with patients via instant messaging to supervise home rehabilitation and increase adherence. Conduct a feasibility study with a pilot sample


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients undergoing reverse shoulder replacement - With a personal smartphone - An instant messaging application installed - Familiar with the use of such an application (i.e., at least three accessess per week) - Able to write and read in the Spanish language Exclusion Criteria: - Condition, whether cognitive, neurological, integrative or musculoskeletal, that obviously prevents understanding or performing the exercises of the rehabilitation program or may pose a risk to the patient's health.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Chatbot
Rehabilitation program based on standard care, but assisted via an instant messaging application using a personal smartphone
Standard car
Rehabilitation program based on standard care, assisted with one education session plus informative brochure

Locations

Country Name City State
Spain Hospital Universitario y Politécnico La Fe València Valencia

Sponsors (2)

Lead Sponsor Collaborator
University of Valencia Hospital Universitario La Fe

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Shoulder disability This is measured with the Quick Dash questionnaire, a self-reported survey of 11 items designed to assess symptoms and ability to perform certain activities. At least 10 items should be answered to calculate a score. Each answer can be scored from one to five, and the average value is calculated, thus obtaining a score from one to five. Then, to express the score in percentages, 1 is subtracted from the result and then multiplied by 25. The higher the score, the greater the disability. 0 weeks, 12 weeks
Secondary Shoulder functionality measured with the Constant-Murley Score, a multi-item functional scale assessing pain, ADL, ROM and strength of the affected shoulder. Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively 0 weeks, 12 weeks
Secondary Shoulder pain Assessed with a numeric pain rating scale, ranging from 0, the worst possible pain, to 10, no pain, with the question: What was your overall pain in the shoulder in the last week? 0 weeks, 12 weeks
Secondary Quality of Life measured with the EQ-5D-5L quetionnaire, which essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. 0 weeks, 12 weeks
Secondary Number of sessions of rehabilitation completed Compliance with rehabilitation, measuring the number of sessions completed 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03540030 - Opioid-Free Shoulder Arthroplasty Phase 4
Recruiting NCT06025331 - Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA? N/A
Recruiting NCT04762667 - Individual Preoperative Planning for RSA N/A
Recruiting NCT06025448 - Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability? N/A
Completed NCT03854357 - Subscapularis Strength After Total Shoulder Arthroplasty N/A
Recruiting NCT05408065 - Comparison of the Analgesic Effect of 2 Shoulder Infiltrations N/A
Recruiting NCT05048264 - Effect of Corticosteroid Injections on Blood Glucose
Recruiting NCT05395819 - Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis N/A
Recruiting NCT06381791 - CBD for Pain Following Orthopedic Shoulder Surgery Phase 1/Phase 2
Active, not recruiting NCT04405297 - A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
Not yet recruiting NCT05868330 - Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties N/A
Recruiting NCT05675527 - PRP for Glenohumeral Osteoarthritis Phase 4
Recruiting NCT06319911 - AETOS Shoulder System
Withdrawn NCT03474510 - Effective Pain Management During Shoulder Replacement Surgery With EXPAREL Phase 4
Completed NCT05043493 - Effect of PRP as Therapy for Shoulder Osteoarthritis N/A
Recruiting NCT05788614 - Retroversion in Reverse Shoulder Arthroplasty N/A
Not yet recruiting NCT06435494 - Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions N/A
Withdrawn NCT04285606 - Effect of Postop Rehab Methods on Outcomes Following Reverse Shoulder Arthroplasty N/A
Recruiting NCT04984291 - Zimmer Biomet Shoulder Arthroplasty PMCF N/A
Not yet recruiting NCT05451550 - The Effects of General Anesthesia and Combined Anesthesia in Controlled Hypotension During Arthroscopic Shoulder Surgery N/A